Investigation into Optimal Administration of Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid and Appropriate Timing of Arterial Phase of Enhanced Liver Magnetic Resonance Imaging for Hepatocellular Carcinoma
Not Applicable
Completed
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000004103
- Lead Sponsor
- Department of Radiology, Graduate School of Medicine, University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with lesions that are received prior RFA or TAE treatment. 2) Patients with a history of hypersensitivity to gadolinium-based contrast agent or this test drug. 3) Patients who have asthma. 4) Patients with severe kidney disease. (eGFR<30mL/min/1.73square meter or serum Cr>1.5mg/dl) 5) Patients during pregnancy or potential pregnancy. 6) Patients who are lactating women. 7) Patients who have advanced nyctophobia cabin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method